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Abstract: GABAA receptors have an age-adapted function in the brain. During early development, they mediate excita-
tory effects resulting in activation of calcium sensitive signaling processes that are important for the differentiation of the
brain. In more mature stages of development and in adults, GABAA receptors transmit inhibitory signals. The maturation 
of GABAA signaling follows sex-specific patterns, which appear to also be important for the sexual differentiation of the 
brain.  
The inhibitory effects of GABAA receptor activation have been widely exploited in the treatment of conditions where neu-
ronal silencing is necessary. For instance, drugs that target GABAA receptors are the mainstay of treatment of seizures. 
Recent evidence suggests however that the physiology and function of GABAA receptors changes in the brain of a subject 
that has epilepsy or status epilepticus.  
This review will summarize the physiology of and the developmental factors regulating the signaling and function of 
GABAA receptors; how these may change in the brain that has experienced prior seizures; what are the implications for 
the age and sex specific treatment of seizures and status epilepticus. Finally, the implications of these changes for the 
treatment of certain forms of medically refractory epilepsies and status epilepticus will be discussed.  
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INTRODUCTION  
 GABA  (-aminobutyric acid) was discovered in the brain 
in 1950 [11, 265, 309] and has since been established as the 
primary inhibitory neurotransmitter in the brain [48, 155]. 
Paradoxically, GABA is derived from the prototypical exci-
tatory neurotransmitter glutamate [265], declaring even from 
its early production steps its role as a shunt of excitatory 
inputs, in a network where the balance between excitation 
and inhibition is very sensitive. GABA can bind to me-
tabotropic GABAB receptors [133, 142, 143, 157, 221, 324] 
or to iono-tropic GABAA or GABAC receptors. Activation of 
postsynaptic GABAB receptors increases membrane conduc-
tance to K
+ leading to prolonged neuronal hyperpolarization. 
Presynaptic GABAB receptor activation reduces Ca
++ con-
ductance and neurotransmitter release. Ionotropic GABAA or 
GABAC receptors are in turn permeable to chloride and bi-
carbonate ions [69]. Classically, activation of GABAA or 
GABAC receptors allows the influx of Cl-, following its elec-
trochemical gradient, resulting in neuronal hyperpolarization. 
However, early during development, ionotropic GABA re-
ceptors mediate depolarizing currents, which activate cal-
cium sensitive signaling processes that are vital for neuronal 
differentiation and brain development. The importance of 
GABA-mediated inhibition in normal brain function and 
diseases stemming from imbalance of excitation and inhibi-
tion is well accepted, thanks to our increasing knowledge of 
brain physiology, pharmacological advances and the pro-
gress of genetics. This has rendered the GABA pathway a 
popular target of pharmacological interventions when exces- 
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sive brain excitation needs to be averted. However, the 
changing role of GABA during development and under cer-
tain pathological conditions has triggered a line of research 
re-evaluating the acute and long term effects of GABAergic 
drugs in the naïve developing brain or the brain that has ex-
perienced insults such as seizures. The current review will 
discuss the current state of knowledge about the dual actions 
of GABA, specifically as they pertain to GABAA receptor 
signaling, in the context of normal brain development or of a 
brain that has experienced seizures.  
GABAA RECEPTORS IN NORMAL BRAIN FUNC-
TION AND DEVELOPMENT 
GABAA Receptors: Structure and Pharmacology 
 GABAA receptors are pentameric channels composed of 
different combinations of subunits, with distinct pharmacol-
ogical, localizing or kinetic properties [17]. In mammalians, 
16 GABAA receptor subunits are known (1-6, 1-3, 1-
3, , , , and ) which form bicuculline-sensitive, ligand-
gated ion channel complexes [7, 24, 94-96, 100, 108, 110, 
113, 132, 150, 168, 174, 175, 186, 194, 208, 233, 269, 276, 
277, 282, 289, 329, 330, 332, 335, 337-339]. Alternate splic-
ing offers additional diversity [18, 55, 152, 160, 248, 325]. 
The inclusion of a  subunit (1 – 3)  distinguishes the 
bicuculline-insensitive GABAC receptor family [27, 36, 50, 
67, 91, 176, 228, 229, 322, 344]. Two more subunits (4
and  4) have been identified in chicken [101, 161]. The 
obligatory components of a functional GABAA receptor 
complex are the  and  subunits, typically 2 from each 
type. Channels formed only as a combination of  and 
subunits can be functional [64, 250], but most frequently, a 
or  subunit is also included. xy complexes are usually 
synaptically located GABAa receptors, mediating phasic in-
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plexes have also been reported [46, 68, 225, 226]. They are 
activated upon the spontaneous or triggered vesicular release 
of GABA and are therefore responsible for phasic GABAA
receptor inhibitory postsynaptic currents (IPSCs). Alterna-
tively, a , , , or  subunit may be included in the receptor 
complex. The presence of a  subunit typically directs the 
GABAA receptor complex to extrasynaptic locations, where 
GABAA receptors are tonically activated by ambient GABA 
[226]. Ambient GABA may rise in cases of excessive synap-
tic GABA release and spillover, as occurs in seizures, or 
through pharmacological blockade of GABA re-uptake 
mechanisms. Less frequently extrasynaptic receptors are 
composed of  or 5 32 or a122 or 332, if highly 
expressed [21, 131, 211, 226, 296].  
  The combination of different subunits determines the 
pharmacological characteristics, kinetics, and subcellular 
localization of the GABAA receptors (reviewed in [208]). 
For example, zolpidem is an 1-selective agonist [207,   
271]; 4,5,6,7-tetrahydroisoxazolo-[5,4-c]pyridin-3-ol (THIP 
or gaboxadol) has highest affinity for -subunit containing 
receptors [2, 298]. Their modulatory domains include bind-
ing sites for benzodiazepines (BZ site), GABA, barbiturates, 
nonbarbiturate anesthetics and ethanol, neurosteroids, picro-
toxin, penicillin, and zinc. Among these, the BZ site is best 
characterized. Typical agonists at the BZ site are diazepam 
and lorazepam, whereas typical antagonist is flumazenil. 
Each receptor complex may have up to 2 BZ sites, each at 
the interface of an  and subunit, and up to 2 GABA sites, 
between an  and subunit. Depending upon the subunit 
composition, BZ sites may have different ligand affinities, 
highest at type I sites (preferably 1-containing), intermedi-
ate at type IIM (preferably 2 or 3- containing) and low at 
type IIL (5-containing) [197]. Among the  subunits, 2 is 
preferred for high BZ affinity [208]. Benzodiazepines have 
high affinity for most  and  subunit containing receptors 
with exception of 4 and 6, and very low affinity for -
containing receptors [207, 208]). Affinity to barbiturates 
affinity is determined by the -subunit [99] and the -
subunit present [307], whereas -containing receptors are 
insensitive to barbiturates and other anaesthetic agents [54]. 
Neurosteroids typically act upon a -containing receptor 
complex, although 112or 312 complexes may be 
responsive to their effects [21, 208]. GABAA receptor ago-
nists can act as GABA-modulatory drugs, altering the effects 
of GABA binding, such as benzodiazepines, or GABA-
mimetic, which directly activate the receptors in the absence 
of GABA, such as muscimol, barbiturates or neurosteroids at 
high doses [185, 187].  
  Apart from GABA, several naturally occurring GABAA
receptor-acting compounds have been identified. The benzo-
diazepine-like compounds diazepam and N-desmethyldiaze-
pam have been detected in rat brain and adrenals [326], bo-
vine cerebral cortex and milk [195], human milk [243] and 
have been localized into synaptic vesicles with immunocyto-
chemical assays [195]. It is yet unclear whether these can be 
synthesized in these organisms in vivo or whether they are 
ingested from food products, such as wheat (diazepam [328]) 
or potato (lormetazepam, desmethyldiazepam, delorazepam, 
lorazepam, delormetazepam [272, 327]). In vivo biosynthetic 
pathways for N-desmethyldiazepam have been described in 
the fungus Penicillium verrucosum [31, 32]. In rat brain, 
active benzodiazepines can be generated in vivo from trypto-
phan [196] or during in vitro incubation [245]. Acinetobacter 
lwoffii, a bacterium of the intestinal or skin flora can produce 
inactive precursors of BZ-like molecules [341]. Pathological 
accumulation of their active benzodiazepine derivatives has 
been described in cases of hepatic failure and may contribute 
to hepatic encephalopathy.
Developmental Changes in GABAA Receptor Structure 
and Pharmacology 
  Most studies describing developmental changes in 
GABAAergic signaling have been done in rats. To better 
understand how might these reflect changes in humans, it is 
generally thought that brain development in a postnatal day 
8-10 (PN8-10) rat is almost equivalent to a newborn human 
baby. The infantile stage in rats spans from PN7-21 and is 
followed by the juvenile stage. Puberty onset in rats occurs at 
approximately P32-37, whereas adulthood is reached at 2 
months [230, 342, 343]. GABA is present in the embryonic 
neural system from the very early days [105, 162]. In the 
embryonic rat neocortex, GABA is detected diffusely as 
early as embryonic day 10 (E10) but after E14 its presence is 
limited to the subplate, cortical plate, marginal and interme-
diate zones [105]. In parallel, GABAA receptors are ex-
pressed, even before the establishment of GABAergic syn-
apses, to permit the autocrine and paracrine actions of 
GABA on brain development [164, 183, 278]. Regional dif-
ferences in subunit expression have been reported in rats, 
with4, 1, 1detected in the premigratory neuroblasts of the 
ventricular zone [164, 183] and 2, 3, 3, 2 at the cortical 
or subcortical plate [164, 183, 190]. The spatiotemporal de-
velopmental patterns of GABA/ GABAA receptor expression 
are thought to be important in the orchestration of the normal 
GABA-related regulation of proliferation and migration or 
neural and glial progenitors [105]. The high levels of GABA 
in the early stages of development promote the proliferation 
of ventricular zone progenitors [105], whereas the subse-
quent decline and restriction of GABAAergic influence 
within the outer neocortical layers inhibits proliferation [8, 
105, 177], enhances migration [20], and may therefore per-
mit further neuronal differentiation. GABAAergic signaling 
is also important for neuronal survival at this stage [128]. In 
further support of the importance of GABAAergic signaling 
for brain development, in utero exposure to GABAA receptor 
inhibitors decreases the number of parvalbumin-immuno-
reactive GABAergic neurons in the striatum, by impairing 
the survival or differentiation of these neurons [182]. More-
over, focal application of GABAAergic agonists in the cortex 
of newborn rats may induce abnormal migration and hetero-
topias [107]. 
  Age-related, species, and region-specific changes, grad-
ual or transient, continue through postnatal development, 
adulthood and ageing for GABAA receptor subunits like 
1, 2, 3, 4, 5, 1, 2[138, 171, 214, 255, 260, 340].
Fritschy et al. have proposed that during the early postnatal 
life, a gradual parallel decrease in 2 / 3and increase in 1
expression occurs in rat brain [74, 120] (Fig. 1). Similar de-
velopmental switch from 2 / 3to1 subunit predominance 
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visual cortex [37, 109]. Functionally, the postnatal increase 
in 1 has been linked to increased sensitivity to neuroster-
oids [214], zolpidem [111] and benzodiazepines [140], and 
acquisition of mature type postsynaptic IPSCs with shorter 
duration [29]. The latter may be important for a brain that 
learns to respond appropriately to novel patterns of neuronal 
activation. Using 1 knockout mice, Bosman et al. have ele-
gantly shown that lack of 1subunits leads to preservation of 
juvenile, long duration IPSCs and impairs spatiotemporal 
excitation patterns to local high frequency stimulation in the 
visual cortex [28, 29]. In the dentate granule cells of the rat 
hippocampus, the developmental switch from 5to 1, 4,
and2subunits correlates with decreasing sensitivity to zinc 
and increase in the affinity for benzodiazepines [34, 140]. 
Sensitivity to zinc is important in the functional regulation of 
GABAAergic transmission, particularly in immature neurons. 
Large amounts of zinc can be stored in synaptic vesicles of 
nerve terminals, as in the hippocampal mossy fibers of the 
immature hippocampus. Stimulation-dependent zinc release 
in this system may therefore be useful to keep under control 
the excessive depolarizing effects of GABA, in a subunit-
specific pattern [16, 53, 166, 285, 331]. This may be less 
important in adult neurons, which lose their sensitivity to 
zinc, as GABAA receptor mediated inhibition is more effi-
cient.
  There is though regional specificity of the evolution of 
these changes [56]. Sex differences in GABAA receptor 
subunit expression further increase the diversity. These in-
clude increased expression of 1 subunit in the female sub-
stantia nigra of infantile and juvenile rats [255] and increased 
1 expression in the male rat juvenile medial preoptic area 
[219]. At the cellular level, GABAA receptor trafficking also 
evolves. Early in development and before synaptic integra-
tion occurs, receptor complexes can be diffusely expressed at 
the cell membrane and can be tonically activated in the pres-
ence of GABA [61, 172, 177, 236, 311]. As the establish-
ment and differentiation of GABAergic synapses begins, 
they initially occupy both extrasynaptic and synaptic sites; 
finally targeting and clustering at synaptic sites and dendritic 
processes increases with maturation and spontaneous IPSCs 
can be detected [1, 236, 253].  
  The temporal, regional, sex, and species specific variabil-
ity in the expression of these subunits in the brain empha-
sizes that generalization across brain regions, species, gen-
ders, and ages is not possible, but one needs to specifically 
study each structure, age, and condition independently. To 
further complicate these studies, handling, caloric restriction, 
and even swim stress regulate GABAA receptor subunit ex-
pression, at times with a lasting effect, suggesting that epige-
netic influences may be as important in shaping the GABAA
receptor related differentiation and communication patterns 
[122, 170, 202, 238]. 
Developmental Aspects of GABAA Receptor Signaling 
 GABAA receptors, almost universally, depolarize very 
immature neurons [22, 23, 130, 177, 181, 198, 215, 235, 
256, 275, 305]. The GABAAergic depolarizations can acti-
vate voltage sensitive calcium channels, increase intracellu-
lar calcium and therefore activate calcium sensitive signaling 
cascades [23, 235, 256] (Fig. 2). These are important for 
normal brain development, as they can control DNA synthe-
sis, proliferation, migration, synaptic growth and integration 
and neuronal differentiation (Fig. 2). For most of the studied 
neuronal types, there is a time in their maturation process, 
usually by the end of the first postnatal month in rats, when 
GABAAergic signaling switches to hyperpolarizing [6, 15, 
42, 79, 82, 97, 124, 127, 147, 149, 158, 167, 258, 261, 279, 
295, 348, 349]. The ionic mechanisms implicated in this 
switch are related to the homeostatic regulation of chloride 
andbicarbonateions,the main ions flowing through the chan-
nel under normal conditions [4, 204, 220, 264, 303, 305].  
  As shown in Fig. (3), intracellular accumulation of chlo-
ride ions is favored when high levels of expression of so-
Fig. (1). Developmental changes in selected GABAA receptor 
subunits, chloride cotransporters (KCC2 and NKCC1) and 
GABAA receptor physiology in rat hippocampus. Upper panel:
A developmental decrease in 2 and 5 in parallel with an in-
crease in a1 has been described in rat hippocampus. Age depend-
ent changes in other subunits, such as 2,3 has also been reported. 
Results are from studies [34, 74, 89, 120, 140, 253, 304]. The 
scale is arbitrary and intends to depict relative changes in expres-
sion of a given subunit across ages, and not the relative abundance 
of one subunit vs another. Lower panel: A switch from an NKCC1-
dominant to a KCC2-dominant state occurs in infantile rat hippo-
campus and has been implicated in the functional switch of GABAA
receptor signaling from depolarizing to hyperpolarizing. Results are 
compiled from studies in male rats or rats of undetermined sex 
[247, 261]. The vertical bar indicates the age when hyperpolarizing 
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dium chloride cotransporters (NCCs), sodium potassium 
chloride cotransporters (NKCCs) or sodium-independent 
anion exchangers (i.e. AE3) occurs. In contrast, decrease in 
intracellular chloride occurs when potassium chloride co-
transporters (KCCs), sodium dependent anion exchangers 
(NDAE) or chloride channel 2 (Clc2) are overexpressed. The 
ionic permeability of these proteins is graphically depicted in 
Fig. (2) and described in Table 1.
  The developmental change in chloride gradient across the 
open channel has long been implicated as a determining fac-
tor for the depolarizing and hyperpolarizing effects of 
GABA [4, 204, 220, 303, 305]. Very immature neurons have 
high intracellular chloride concentrations ([Cl-]i) that shift 
the equilibrium potential for Cl 
-(ECl-) to values less negative 
than the resting membrane potential (Vm). As a result, open-
ing of a GABAA receptor channel leads to efflux of Cl 
-
,
which depolarizes the neuronin an attempt to reach ECl-. Ma-
ture neurons have low [Cl-]i, ECl- values more negative than 
Vm, and hyperpolarizing responses to GABAA receptor acti-
vation. The molecular characterization of chloride cotrans-
port mechanisms (Table 1, Fig. 3) offered a first insight into 
the developmental regulation of GABAAergic signaling. 
Cation chloride cotransporters (CCCs) mediate the elec-
troneutral transport of Cl-along with either K+ (potassium 
chloride cotransporters, KCCs) or K+ and Na+ (sodium po-
tassium chloride cotransporters, NKCCs) or Na+ only (so-
dium chloride cotransporters, NCCs) [60, 268]. Under nor-
mal conditions, KCCs extrude K+ / Cl-, decreasing intracel-
lular Cl-, whereas NKCCs and NCCs import cations and Cl- 
into the cell, increasing intracellular Cl-. During the devel-
Fig. (3). Schematic depiction of selected proteins involved in the 
regulation of Cl- homeostasis.  
Upper panel: Cl- accumulation is effected by the presence of the 
Na+/Cl- Cotransporter NCC and Na+/K+/Cl- Cotransporter
NKCCs, with main representative being NKCC1. Their function is 
dependent upon the supply of Na+ by the Na+/K+ ATPase. In con-
trast,  Anion Exchangers, like AE3, favor Cl- accumulation in a 
sodium independent manner. Lower panel: Low intracellular Cl- 
concentration occurs as a result of K+/Cl- Cotransporters, such as 
KCC2, which export Cl- and K+. As a result, their function is also 
dependent upon K+ supply by Na+/K+ ATPases. The Sodium De-
pendent Anion Exchangers NDAE and Chloride Channel 2
(Clc2) also decrease intracellular Cl-[69, 268]. 
Fig. (2). The developmental switch in chloride cotransporter 
(CCC) expression drives the functional switch of GABAA recep-
tors from depolarizing to hyperpolarizing. The developmental 
increase in KCC2 and, in certain tissues, the decrease in NKCC1 
triggers the switch from depolarizing to hyperpolarizing 
GABAAergic signaling [247, 261]. GABA-mediated depolariza-
tions activate L-type voltage sensitive calcium channels   
(L-VSCC) and release the Mg++ block of NMDA receptors, in-
creasing intracellular Ca++. This can activate calciumregulated 
signaling pathways, which are important in neuronal develop-
ment, migration, proliferation, synaptogenesis and differentia-
tion. The GABA-mediated activation of calcium signaling does 
not occur in neurons with hyperpolarizing GABAA receptor 
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Table 1.  Selected Proteins Involved in Cl- Transport [106, 241, 268]. 
Protein  Ion Permeability  Features  Inhibitors  Disease Linkage  References 
Cation chloride cotransporters 
Potassium Chloride Cotransporters (KCCs)      [57, 77, 86, 134, 
259] 
KCC1 (SLC12A4)  Ubiquitous   N/A  [86, 88, 119, 134, 
227, 242, 299, 347, 
350] 
KCC2 (SLC12A5)  Neuronal specific  N/A  [77, 86, 134, 234, 
239, 263, 290, 346] 
KCC3 (SLC12A6)  Widespread expression: 
heart, kidney, neurons, 
epithelia, red blood 
cells, muscle, placenta 
ACCPN ; 
variants with 
bipolar disease 
[86, 115, 121, 200, 
201, 213, 252] 
KCC4 (SLC12A7) 
Efflux of K+, Cl- 
Widespread expression; 
weak in brain 
Inhibited by: 
Furosemide > bumetanide, DIOA, 
ATP, Hypertonic media, Disulfonic 
acid stilbene  
High extracellular K+, WNK, 
SPAK 
Activated by: 
Hypotonic media; N-ethylmaleimide; 
PDGF (KCC2); 
PKA (KCC2)  N/A  [86, 169, 213, 312] 
Sodium potassium chloride cotransporters (NKCCs)       
NKCC1 (SLC12A2; 
BSC2) 
Ubiquitous N/A  [49, 59, 77, 134, 
210, 240, 246, 247] 
NKCC2 (SLC12A1; 
BSC1) 
Influx of Na+, 
K+, 2Cl- 
Kidney 
Inhibited by: 
Bumetanide > Furosemide 
PP-1 
Activated by: 
ATP, Hypertonic media, Calyculin A, 
Low Cl  
WNK,  
SPAK (NKCC1) 
Bartter’s syn-
drome type I 
[76, 126, 188, 259, 
284] 
Sodium chloride cotransporters (NCCs) 
Sodium chloride co-
transporter 
(SLC12A3; NCC) 
Influx of Na+, 
Cl- 
Kidney Inhibited  by: 
Thiazides 
Activated by: 
WNK 
Gitelman’s 
syndrome 
[259] 
Chloride channels 
Cl- channel 2 (Clcn2 
or Clc2) 
Efflux of Cl-  Brain (neurons), heart, 
pancreas, lung, liver, 
fibroblasts, epithelial 
Inhibited by: 
PP-1 
Activated by: 
Hyperpolarization, cell swelling, 
acidic pH, hypo-osmotic shock, ara-
chidonic acid, omeprazole, 
p34(cdc2)/cyclin B; PKA 
Idiopathic gen-
eralized epilepsy 
[25, 47, 52, 72, 
75, 102, 222, 
286, 306]  
Selected HCO3- transporters 
Na+-dependent anion 
exchanger NDAE 
(SLC4A8; NDCBE) 
Influx Na+, 
HCO3-;  
Efflux H+, Cl- 
Brain, testis, kidney, 
ovary 
Inhibited by: 
DIDS  
Activated by: 
ATP requirement (squid) 
N/A [92,  267] 
Na+-independent 
anion exchanger AE3 
(SLC4A3) 
Influx Cl-; Efflux 
HCO3- 
Brain, retina, heart, 
smooth muscle, epithe-
lia 
Activated by: 
Increased intracellular pH 
Idiopathic gen-
eralized epilepsy 
[267, 273] 
Abbreviations: ACCPN: Agenesis of Corpus Callosum with Peripheral Neuropathy; DIDS: 4,4’-diisothiocyano-2,2’-stilbene disulphonic acid; PP-1: protein phosphatase 1; PKA: 
protein kinase A; PDGF: platelet derived growth factor; WNK: With No lysine (K); SPAK: Serine Proline Alanine lysine (K) rich; OSR:  oxidative stress responsive kinase; DIOA: 
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opmental period when GABAA receptor signaling switches 
from depolarizing to hyperpolarizing in the hippocampus, 
theexpression ofkeyrepresentatives of these families changes: 
NKCC1 decreases [247] whereas KCC2 increases [179, 261], 
with net result the decrease in intracellular Cl-. Furthermore, 
they are sufficient to trigger the switch as shown with in
vitro or in vivo antisense inhibition [124, 261, 302, 351], 
overexpression of KCC2 or NKCC1 [6, 39, 165] or pharma-
cological inhibitors of CCCs [333]. Similar age- and matur-
ity-related changes in the expression of these cotransporters 
have been described in many neuronal structures [43, 79, 
169, 179, 203, 281, 295, 316, 319]. Other factors that may 
contribute to the increased functionality of KCC2-mediated 
Cl-export in mature neurons is its more efficient localization 
at the plasma membrane and oligomerization [14, 26]. For 
NKCC1, a shift from a neuronal pattern to a glial-dominant 
pattern of expression has been described in the developing 
murine nervous system [123].  
  In normal humans, it is obviously difficult to identify the 
timing of the GABAA receptor switch and related changes in 
CCCs. Using human brain tissue from patients deceased 
from non-neurological disorders, similar developmental in-
crease in KCC2 over NKCC1 was identified in the cortex 
postnatally, suggesting that a similar gradient of GABAAer-
gic responses may occur [65]. Comorbid conditions and 
medical treatments, which are known to influence CCC ex-
pression and GABAA receptor signaling, may, to an extent, 
have influenced the expression of these proteins. However, 
the resemblance of these patterns with the biology of the 
system in the experimental studies strongly supports the hy-
pothesis that depolarizing GABAAergic responses may in-
deed occur at least in prematurely born neonates.  
  Another level of complexity stems form recent findings 
that the maturation of GABAAergic signaling and its regula-
tors may occur earlier in females than in males. In the sub-
stantia nigra pars reticulata (SNR), the expression of KCC2 
mRNA is always higher in female than in male GABAergic 
SNR neurons (infantile and juvenile period) [79]. This ex-
plains the earlier appearance of hyperpolarizing GABAAer-
gic responses in females than in males [79, 158]. Similarly, 
earlier appearance of hyperpolarizing GABAAergic signaling 
was seen in dopaminergic neurons of the female rat substan-
tia nigra pars compacta (SNC) [82]. As a result, during the 
sensitive developmental windows of divergent GABAAergic 
signaling, physiological or pathological activation of these 
receptors may have distinct translational consequences in 
males and females. For instance, in male infantile (PN15) SN 
neurons, GABAAergic depolarizations increase intracellular 
calcium, the expression of the phosphorylated form of the 
transcriptional factor CREB (cAMP responsive element 
binding protein), as well as the expression of calcium regu-
lated mRNAs, such as KCC2 [79, 80, 82]. These do not hap-
pen in female PN15 SN neurons, in which GABAAergic ac-
tivation downregulates KCC2 mRNA [79]. Furthermore, 
GABAA receptor signaling also interferes with estradiol sig-
naling. Estradiol downregulates KCC2 mRNA only in neu-
rons which are depolarized by GABAA receptors [80] but not 
in neurons which are either hyperpolarized by them or in 
which GABAA receptors have been blocked [80, 218] (Fig. 
4). These direct and indirect actions support that, in normal 
development, GABAA receptors can act as broadcasters of 
sexually differentiating signals in the brain promoting its 
sexual differentiation [81].  
Fig. (4). Differential regulation of KCC2 in neurons with depo-
larizing or hyperpolarizing GABAAergic signaling. GABAA
receptor activation and BDNF increase KCC2 in immature neu-
rons with depolarizing GABAAergic responses, but decrease it 
in neurons with hyperpolarizing GABAAergic signaling. Estra-
diol (E) downregulates KCC2 only in neurons with depolariz-
ing GABA. Testosterone and its androgenic products (T) in-
crease KCC2 in both conditions [3, 35, 81, 262, 263, 317].
  In addition, the intracellular concentrations of Cl-and 
HCO3- are regulated by anion exchangers (AE). The sodium 
independent electroneutral AEs exchange HCO3- for ex-
tracellular Cl-, lowering intracellular pH and increasing Cl- 
[112, 300, 336]. Sodium Dependent Anion (Cl- / HCO3-) 
Exchangers (NDAE), also called sodium-dependent Cl-
/HCO3- exchangers (NDCBE or NCBE) function in the op-
posite direction increasing intracellular pH and lowering 
intracellular Cl-[87, 92, 151, 287, 288, 315, 321]. The ex-
pression of NCBE precedes KCC2 in the embryonic mouse 
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eral nervous system and epithelial non-neuronal tissues 
[125].  
  Finally, the hyperpolarization-activated chloride channel 
Clc2 has been implicated in maintaining low intracellular Cl- 
[41, 102, 283, 292]. Clc2 mediated Cl- efflux is also en-
hanced by extracellular acidosis. Low expression of func-
tional Clc2 has been reported in the rat neonatal hippocam-
pus and has been correlated with the depolarizing actions of 
GABAA receptors at this age [205]. Clc2 has also been pro-
posed to be a key factor in maintaining low intracellular Cl- 
in adult dopaminergic neurons of the rat SNC [93].  
 GABAA receptors are also permeable to HCO3-. As   
the equilibrium potential for HCO3-is approximately 50mV 
less negative than the resting potential, HCO3-flux is usually 
outward [294]. This renders the reversal potential of 
GABAAergic inhibitory postsynaptic currents (EGABA) less 
negative than the ECl-, although its contribution is much 
smaller compared to Cl- [5, 135, 136]. Upregulation of a 
cytosolic carbonic anhydrase (CAVII), which catalyzes the  
production of HCO3-from CO2, occurs in hippocampal py-
ramidal neurons around PN12, promoting the depolarizing 
GABAAergic responses following high frequency repetitive 
stimulation [264]. 
  An important distinction should be made though between 
the ability of GABAA receptor activation to depolarize a neu-
ron as opposed to excite a network into epileptiform dis-
charges or seizure activity. GABA-mediated depolarizations 
can often reach the threshold for activation of voltage gated 
calcium channels, such as the L-type channels, or for release 
of Mg++ block of NMDA receptors (Fig. 2). As a result 
these processes can increase intracellular calcium and acti-
vate calcium-sensitive signaling, with its known impact on 
brain development and differentiation. However, if the level 
of neuronal activation begins to exceed EGABA, which is very 
close to ECl-, the open GABAA receptors start to shunt excita-
tion, by reversing Cl- flux, in an effort to maintain the neu-
ronal potential close to EGABA [293]. Undoubtedly, in condi-
tions when EGABA has shifted to significantly more positive 
values, even shunting inhibition can fail and this may explain 
reports of ictogenic properties of GABA [145, 209].  
Regulation of Chloride Cotransporters and GABAA Re-
ceptor Signaling Switch 
  The functional importance of the switch of GABAAergic 
signaling generated a lot of interest around regulatory factors 
underlying this process. Karadsheh and Delpire sequenced 
portions of the 5’ region upstream to KCC2 gene and identi-
fied a 21bp element with 80% similarity to the neuronal-
restrictive silencing factor binding consensus sequence 
(NRSE) that may function as gene silencer [141]. Although 
this finding is in good alignment with the neuronal specific-
ity of KCC2, further studies showed that KCC2 lacking this 
NRSE sequence remains neuronal specific; moreover, in the 
absence of this NRSE, KCC2 shows similar developmental 
increase as the normal gene [310].  
  A number of studies have also investigated the regulation 
of KCC2 and GABAAergic switch by GABA signaling, 
showing that depolarizing GABAAergic signaling is a posi-
tive drive for the developmental upregulation of KCC2 and 
switch of GABAA receptors, mediating its effects through 
activation of voltage-sensitive calcium channels and activa-
tion of calcium signaling. Nevertheless it is not necessary, 
since in its absence the increase in KCC2 and GABAAergic 
switch still occurs, albeit at a later timepoint. These have 
been shown in vitro using E18 dissociated rat hippocampal 
cultures [85] and rat E14 ventral midbrain neurons [308]. 
Further support has been provided with the effects of in vivo
administration of GABAAergic agonists and antagonists on 
KCC2 and GABAA receptor switch in rat SNR [79] and tur-
tle retina [167]. The sexually dimorphic features of the PN15 
rat SNR have provided us with a convenient in vivo system 
to study KCC2 regulation in normal neurons with similar 
chronological age, which have either depolarizing (male) or 
hyperpolarizing (female) GABAAergic signaling. The 
GABAAergic agonist muscimol increases KCC2 mRNA in 
male neurons, via activation of voltage sensitive calcium 
channels and calcium signaling [79, 80]; in contrast, musci-
mol decreases KCC2 mRNA in female SNR neurons with 
hyperpolarizing GABAAergic responses [79]. These indicate 
that the maturational state of a neuron, as it relates to the 
mode of GABAAergic signaling, is critical in defining its 
reaction to stimuli that tend to disturb its GABA-related de-
velopmental pathway. On a separate note, Ludwig et al. did 
not observe any changes in KCC2 immunoreactivity in cul-
tured PN0-1 hippocampal mouse neurons chronically treated 
with either picrotoxin and the sodium channel inhibitor tet-
rodotoxin (TTX) or combinations of TTX with glutamate 
receptor inhibitors, proposing that these are not necessary for 
the developmental increase in KCC2, in hippocampus [180]. 
Some of the differences in these results may be due to a 
combination of factors, such as the different maturational 
stages of the studied cells (embryonic rat vs postnatal mouse 
hippocampal), or the different combinations and doses of 
inhibitors.  
  Another approach to dissect whether neuronal activation 
promotes the maturation of the GABAAergic system has 
been through sensory deprivation or lesioning of the natural 
afferent stimulatory pathways to sensory nuclei. Unilateral or 
bilateral cochlear ablations prior to the onset of hearing, 
maintained KCC2 expression at low levels and prevented the 
developmental decrease in intracellular chloride – at least 
within the time frame of the study -, within the lateral supe-
rior olivary nucleus of the developing rat (~PN15) [280]. In 
turtle retina, dark rearing inhibited the developmental in-
crease in KCC2 and prolonged the period of excitatory 
GABAAergic responses [279].  
  Brain derived neurotrophic factor (BDNF) is a neurotro-
phic factor that has been implicated both in normal neuronal 
activity patterns, as well as in the mediation of long term 
effects of excessive and pathological patterns of neuronal 
excitability [3]. BDNF expression is high in the first 2-3 
postnatal weeks and subsequently declines to adult levels 
(limbic system, rat ventral mesencephalon of voles) [173, 
224]. BDNF exerts opposite effects on KCC2 expression, 
depending on the developmental stage of the target neuron. 
In developing neurons, BDNF increases KCC2 expression 
[3, 35], whereas in mature neurons BDNF decreases KCC2 
and causes a positive shift of EGABA [262, 263, 317]. Rivera 
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mediated downregulation of KCC2 [263]. The PLC (phos-
pholipase C) signaling downregulates whereas Shc signal-
ing upregulates KCC2 in their system [263]. The develop-
mental and cell type specific expression of these signaling 
pathways may be therefore important in the developmental 
regulation of KCC2 by BDNF.  
  CCCs are also functionally regulated by post-
translational modifications. Tyrosine phosphorylation of 
KCC2 by insulin-like growth factor (IGF-1) and tyrosine 
kinases increase its activity [144]. Members of the serine-
threonine kinase WNK (With No lysine (K)), SPAK (Serine 
Proline Alanine lysine (K) rich), and oxidative stress re-
sponsive (OSR) kinase families have drawn much focus in 
related research, showing that they are important, coopera-
tively or independently, in the activation of NKCC1, 
NKCC2, NCCs and de-activation of KCCs [77, 86, 134] 
[259] [57]. These interactions are important for the volume-
regulation of CCC activity. Activation of protein kinase A 
pathway (PKA) pathway, through its effects on protein phos-
phatases, has been implicated in the activation of KCC2 
following high frequency stimulation of PN2-3 rat neurons at 
the deep cerebellar nuclei [234]. Platelet-derived growth fac-
tor (PDGF) activates KCC2 via the PI 3-K / PP-1 pathway 
(phosphoinositide 3-kinase / protein phosphatase-1) [346]. 
Although certain systems may be more sensitive to modula-
tors of the activity of similar kinases [148], it is not yet 
known how they contribute to the developmental changes in 
CCC activity and Cl- regulation.  
  Hormonal regulation of CCC function is also important 
during development, given the ongoing neuroendocrine 
changes occurring at this period, which are important for 
brain development. We have studied the regulation of KCC2 
by sex hormones in PN15 SNR, using in vivo injections. Tes-
tosterone and its androgenic derivative dihydrotestosterone 
both increased KCC2 mRNA expression acutely and this 
effect was sustained after repetitive doses. This androgenic 
effect was observed both in male and female SNR, suggest-
ing that it can occur regardless of the direction of GABAAer-
gic signaling [80]. Interestingly, 17-estradiol was effective 
in decreasing KCC2 mRNA only in SNR neurons with depo-
larizing GABAAergic signaling, suggesting an interaction of 
the two pathways [80]. In accordance with these findings, 
estrogens failed to regulate KCC2 expression in the pyrami-
dal region of the hippocampus of adult ovariectomized fe-
males, which likely have mature GABAAergic responses 
[218].  
Implications for Normal Development and Physiology 
  In embryonic and immature neurons, GABA has neu-
rotrophic properties: it regulates the proliferation, migration 
and differentiation of neurons, dendritogenesis and synapto-
genesis, increases the number of neurotubules, rough endo-
plasmic reticulum, Golgi apparatus, synaptic vesicles [20, 
23, 39, 105, 291]. As the functional recruitment and re-
quirements of each neuronal structure during development 
changes with different tempos, it is not surprising that the 
maturation of the GABAAergic signaling pathway occurs at 
different timepoints for each cell type. The sensitive regula-
tion of GABAAergic signaling by neuronal activity, patterns 
of sensory input, epigenetic factors, hormonal influences, 
interaction with other signaling pathways ensures that brain 
development will occur in a patterned but also time-, con-
text-, sex-, and experience-driven fashion. This asynchro-
nous maturation may at times be important for structured 
communication between different cell types [320] or genera-
tion of specific activity patterns [279]. On the other hand, it 
also renders it very vulnerable to dysfunction in case of 
pathological influences, as will be described in the subse-
quent sections. 
GABAA RECEPTORS IN SEIZURES AND EPILEPSY 
 GABAA ergic drugs are the mainstay of treatments to 
suppress seizures [118, 199, 249, 266, 323]. They are pri-
mary or secondary targets of many of the available anticon-
vulsants [199]. These include drugs enhancing GABAA re-
ceptor action through a direct interaction with the receptor 
(benzodiazepines, barbiturates, propofol, stiripentol, topi-
ramate, carbamazepine, phenytoin, felbamate) or indirectly 
by increasing the available GABA (tiagabine, vigabatrine, 
gabapentin, valproate) [51, 90, 156, 199, 251]. Furthermore, 
anticonvulsants can reduce the depolarizing effects of 
GABAA receptors by inhibiting carbonic anhydrase (topi-
ramate, zonisamide, acetazolamide) [58, 63, 192, 223, 257].  
 GABAA receptors may influence the susceptibility to 
seizures. A variety of epileptic or seizure syndromes have 
been linked to genetic mutations of GABAA receptors, which 
compromise their function (Table 2). Seizures are most 
prevalent during the neonatal and infantile period, a time 
when the brain has not fully matured [103, 104, 212].   
Although it is difficult to extrapolate experimental data to 
humans, this is the time when expression, efficacy, subcellu-
lar localization of GABAA receptors, and functional matura-
tion of GABA-driven subcortical seizure-controlling net-
works have not been fully optimized [314]. For example, 
GABAAergic activation of the anterior SNR exerts procon-
vulsant effects in PN15 rats but anticonvulsant effects in 
PN30 male rats [313]. Moreover, shunting inhibition, due to 
the depolarizing EGABA is expected to be less efficient. This 
was nicely demonstrated both in vitro and in vivo by Dzhala 
et al. who showed that bumetanide, an NKCC1 inhibitor, can 
suppress ictal activity in very young rats [65]. Its efficacy 
dropped though in older ages, probably due to the decreased 
expression of NKCC1. In older preparations or subjects, 
anticonvulsant efficacy has been demonstrated for com-
pounds potentially inhibiting other age-appropriate mecha-
nisms mediating GABAA-depolarizations. These include 
thiazides and carbonic anhydrase inhibitors (acetazolamide) 
[114, 189, 274]. Furosemide, a loop diuretic preferentially 
inhibiting KCC2 over NKCC1, has been shown to have anti-
convulsant activity, but its effect has been linked to a de-
crease in neuronal synchronization and cell volume regula-
tion [116].  
  By far the most common type in patients with intractable 
epilepsy is temporal lobe epilepsy (TLE) [12, 30, 66, 78]. In 
most cases, TLE has not been linked to genetic factors. TLE 
patients commonly have a history of an initial precipitating 
event (IPI), including prolonged neonatal seizures [193]. As 
a result, intense research is undergoing to reveal how 
changes in GABAAergic signaling interfere with the acquired 
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refractoriness. In human specimens from resected temporal 
lobes of patients with TLE and hippocampal sclerosis, the 
associated neuronal loss results in decreased cell counts of 
GABAA receptor immunoreactive cells in the vulnerable re-
gions (CA1, CA3, hilus) [178]. The surviving neurons and 
interneurons show changes in morphology, expression and 
subcellular distribution of GABAA receptor subunits that 
partially correspond to patterns seen in younger age groups, 
based in the experimental studies. Specifically, these changes 
include increase in 2, 1, 2, 3, 2 subunit expression in 
the somata and apical dendrites but reduction in basal den-
drites, decreased 1 expression in sectors CA1, CA2, and 
CA3, decrease of 1 and increase of 2 in CA2 [178]. Phar-
macologically, these studies may be interpreted as suggest-
ing that the epileptic state may be associated with less sensi-
tivity to GABAAergic drugs, specifically to benzodiazepines, 
at least in certain hippocampal neurons. Using flumazenil 
(benzodiazepine antagonist) PET study, Chugani et al. stud-
ied a cohort of patients with epilepsy (2-17 years old) and 
found an age-related decrease in flumazenil volume of dis-
tribution; this change occurred earlier in the subcortical re-
gions [40]. From the experimental models, it is obvious that 
some of these changes may occur after prolonged seizures and 
may, at least in certain cases, be long lasting or permanent 
(Fig.  5). Interestingly, the effects of prolonged seizures on 
GABAA receptor expression and function are different in 
younger rats (Fig. 5), an observation that may partially ex-
plain the different outcomes of SE in very young vs older 
subjects. Despite its higher susceptibility to seizures, the 
immature brain is relatively more resilient to acute injury, 
epileptogenesis and long term cognitive dysfunction than the 
mature brain [78, 212].  
  Beyond its role in suppressing seizures, several groups 
have proposed that GABAAergic signaling, under certain 
conditions, contributes to the appearance of interictal epilep-
tic discharges by increasing neuronal synchronization [13, 
153, 154]. An important study that re-focused the interest 
upon the role of depolarizing GABA in human mesial TLE 
was published in 2002 [44]. The authors showed that interic-
tal-like activity detected in vitro from the subiculum of pa-
tients who underwent resective surgery for mesial TLE was 
blocked by either GABAA or glutamate receptor antagonists. 
This was associated with a positive shift in EGABA of the py-
ramidal subicular neurons. Palma et al. independently con-
cluded that cell membranes from human epileptic tissue, 
when injected into Xenopus oocytes, elicited depolarizing 
Table 2.  Epileptic and Seizure Syndromes Associated with Abnormalities in GABAAergic Signaling 
Gene Defect  Epileptic Syndrome  Proposed Dysfunction  Reference 
GABAA receptor subunits
1 (GABRA1)  Autosomal dominant juvenile myo-
clonic epilepsy (ADJME)
Low amplitude GABA currents; reduced surface expression; in-
creased GABA EC50
[45, 184]
3 (GABRB3)  Childhood absence epilepsy  [71]
Deletion in 15q11-q13 
(includes 3, 5, 3)  
Angelman syndrome  [159, 301] 
Autosomal dominant epilepsy with 
febrile seizures plus (ADEFS+)
Impaired Cl- influx or potentiation by endozepine [19] 
Febrile seizures + childhood ab-
sence epilepsy 
Impaired sensitivity to benzodiazepines; accumulation of desensi-
tized receptors; endoplasmic reticulum retention; temperature-
sensitive trafficking defect
[70, 137, 139, 
184, 191, 270, 
318]
ADEFS+ including a patient with 
severe myoclonic epilepsy of in-
fancy (SMEI)
endoplasmic reticulum retention  [98] 
2 (GABRG2) 
Febrile seizures Increased fast phase desensitization, reduced sensitivity to diazepam [10, 38]
ADEFS+  Low amplitude GABA currents [62]
ADEFS+, idiopathic generalized 
epilepsies (IGE), febrile seizures, 
but also controls 
Low amplitude GABA currents [62]  
 (GABRD) 
ADJME Low amplitude GABA currents [62]
Proteins involved in Cl- regulation
AE3 (SLC4A3)  IGE Abnormal Cl- homeostasis ? [273]
Clc2 (Clcn2) IGE Lower transmembrane Cl- gradient, altered voltage-dependent gat-
ing
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GABAAergic currents, which was linked to upregulation of 
NKCC1 and downregulation of KCC2 [237]. Bertelli et al.
have recently reported decreased levels of a Clc2 isoform in 
epileptic temporal lobes [25]. Furthermore, in patients with 
cortical dysplasias and intractable epilepsy, high expression 
of NKCC1 and abnormal subcellular distribution of KCC2 
has been shown by 2 groups [9, 216]. Similar observations 
have been obtained in experimental models of seizures. Hip-
pocampal kindling of adult mice decreased KCC2 expression 
in the hippocampus, through activation of the BDNF / trkB 
pathway [262]. Amygdalar kindling of adult rats increased 
NKCC1 in the piriform cortex [231] and dentate gyrus [232]; 
decreased KCC1 and Clc2 in the dentate gyrus and Clc2 in 
the CA1 pyramidal region of the hippocampus, but had no 
effect on KCC2 [232]. In their in vitro model of mirror epi-
leptogenic focus, Khalilov et al. describe that seizure propa-
gation to a drug-naïve hippocampus aberrantly switches 
GABAAergic signaling back to its immature depolarizing 
mode and this is important for the generation of ictal patterns 
[145, 146]. It should be noted that all these studies pertain to 
neurons, which at the time of seizures had mature-type, hy-
perpolarizing GABAAergic responses. Given the divergent 
patterns of regulation of KCC2 in neurons with depolarizing 
vs hyperpolarizing GABAAergic signaling (Fig. 2), can these 
observations be extended to neonatal and pediatric epilep-
sies, when the brain is still immature?  
 Isaeva  et al. induced repetitive but brief flurothyl-induced 
seizures (not SE) in neonatal rats [129]. In their model, they 
failed to see any significant effect of neonatal seizures on the 
timing of GABAAergic switch in the CA3 region of the hip-
pocampus, albeit the amplitude of IPSCs was reduced. More 
severe and prolonged seizures induced as 3 neonatal epi-
sodes of kainic acid-induced SE, increase KCC2 mRNA 
expression in the CA3 pyramidal region of the male rat hip-
pocampus [83]. A possible explanation is that activation of 
BDNF and GABAAergic signaling during neonatal SE may 
actually upregulate KCC2 (Fig. 2). Both these studies sup-
port that the seizure-induced re-appearance of depolarizing 
GABAAergic responses observed in mature neurons is un-
likely to occur in the neonatal brain with immature 
GABAAergic signaling. If indeed the epileptic state is linked 
with aberrant maintenance of depolarizing GABAAergic sig-
naling, these findings may explain why neonatal rats are 
relatively resistant to the development of epilepsy following 
neonatal SE. Further studies are underway to fully character-
ize the effects of neonatal seizures on chloride homeostasis 
and GABAAergic switch and determine how these may con-
Fig. (5). Schematic depiction of the timeline of changes in GABAA receptor subunit mRNA expression in the hippocampus, in rodent 
models of temporal lobe seizures and epilepsy.  
The effects of SE change according to age of induction, model, and species. In most cases, the results stem from the lithium-pilocarpine or 
pilocarpine SE model, except for the results marked with an asterisk, which were described after kainic acid SE. Adulthood starts at PN60. 
The time scale used for the effects of SE in adult rats is approximate and is meant to reflect changes during the latent phase of epileptogene-
sis, prior to the onset of spontaneous seizures, and during the epileptic phase, ie after the occurrence of 2 spontaneous seizures. The diagrams 
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tribute to the different outcome of neonatal seizures on brain 
development [78, 117].  
  Finally, a number of conditions that increase risk of sub-
sequent epilepsy induce aberrant switch of hyperpolarizing 
to depolarizing GABAAergic signaling in mature neurons. 
These include hypoxia [84], axonal injury [217]. Interest-
ingly, hypoxia in immature neurons decreases intracellular 
Cl- [334]. 
CONCLUSIONS  
  There is undoubtedly wide region, sex, age, species, ex-
perience-driven diversity in GABAAergic signaling. These 
differences may seem subtle, often identified only with sen-
sitive pharmacological, electrophysiological or immunologi-
cal tools, suggesting that its complex components serve as 
fail-safe mechanisms to preserve an important homeostatic 
mechanism. Their temporal evolution serves sex-, cell type-, 
and age-appropriate functions: neurotrophic and morphoge-
netic early in development; activity-driven plasticity at the 
time when environmental cues make their maximal imprint 
on the structural and functional organization of the brain; and 
finally inhibitory and neuromodulatory when the mature 
brain needs to homeostatically preserve its learned patterns 
of activity. A key feature of the immature type function of 
GABAA receptors is the depolarizing signaling, attributed to 
the inability of young neurons to maintain low intracellular 
chloride. This is critical for age- and sex-appropriate brain 
development and differentiation. Of equal importance is to 
keep in mind that the regulation of GABAAergic switch is 
different in neurons with depolarizing vs hyperpolarizing 
GABAAergic signaling. In mature neurons, recurrent and 
prolonged seizures may trigger a pathological reemergence 
of immature features of GABAA receptors, which compro-
mises the efficacy of GABA-mediated inhibition. In imma-
ture neurons with depolarizing GABAAergic signaling, the 
physiological and pathological regulation of this system is 
completely different, possibly contributing to the different 
outcomes of early life seizures. Moreover, since disturbing 
the timing of GABAAerging switch can potentially have long 
lasting effects on brain development and differentiation, it 
becomes increasingly more urgent to design sex- and age-
specific pharmacological interventions adapted for the matu-
rational stage of the targeted brain region, so as to limit side 
effects. Of particular relevance is the further characterization 
of the long-term effects on naïve fetuses exposed in utero to 
maternal use of drugs acting on this system.  
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